Guerbet

Update in progress

GBT.PA (Paris)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Guerbet SA provides contrast media, medical devices, and AI-enabled imaging solutions for diagnostic and interventional radiology worldwide. Its products include DOTAREM and Elucirem gadolinium MRI agents; CT/angiography agents such as Conray, Micropaque, Optiray, Telebrix Gastro, and Xenetix; Lipiodol Ultra Fluid; and a range of delivery injectors and accessories (OptiStar Elite, OptiOne, Illumena Néo). Founded 1901, based in Villepinte, France.

Company score

Sentiment: -0.28; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.12; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.12; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.24; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.05; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.16; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive